| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.01 | 0.8 |